Myxoid leiomyosarcoma of the uterus

Histopathology

Volumn 59, Issue 6, 2011, Pages 1144-1155

  Burch, David M ^a,b   Tavassoli, Fattaneh A ^a,c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioinvasion; Infiltrative margins; Leiomyosarcoma; Myxoid

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER RADIOTHERAPY; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MITOSIS INDEX; MYOMETRIUM; MYXOID LEIOMYOSARCOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; SMOOTH MUSCLE FIBER; TUMOR GROWTH; TUMOR VOLUME; UTERUS BLEEDING; UTERUS SARCOMA;

ADULT; AGED; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; MITOTIC INDEX; NECROSIS; UTERINE NEOPLASMS;

EID: 84855939915     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04053.x     Document Type: Article

References (38)

1. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. Am. J. Surg. Pathol. 1994; 18; 535-558.
2. King ME, Dickersin GR, Scully RE. Myxoid leiomyosarcoma of the uterus. Am. J. Surg. Pathol. 1982; 6; 589-598.
3. Aida Y, Tadokoro M, Takeuchi E et al. Myxoid variant of epithelioid leiomyosarcoma of the uterus. Acta Pathol. Jpn 1991; 41; 778-783.
4. Atkins K, Bell ME, Mepson R, Hendrickson M. Myxoid smooth muscle tumors of the uterus. Mod. Pathol. 2001; 14; 132A.
5. Botsis D, Koliopoulos C, Kondi-Pafitis A, Creatsas G. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report. Int. J. Gynecol. Pathol. 2006; 25; 173-175.
6. Chang E, Shim SI. Myxoid leiomyosarcoma of the uterus. A case report and review of the literature. J. Korean Med. Sci. 1998; 13; 559-562.
7. Chen KT. Myxoid leiomyosarcoma of the uterus. Int. J. Gynecol. Pathol. 1984; 3; 389-392.
8. Delmonte V, Marino F. Leiomyosarcoma mixoide uterino. Rev. Hosp. Clin. Fac. Med. S. Paulo. 1985; 40; 200-202.
9. Fraga M, Prieto O, Garcia-Caballero T, Beiras A, Forteza J. Myxoid leiomyosarcoma of the uterine cervix. Histopathology 1994; 25; 381-384.
10. Fukunishi H, Yukimura N, Takeuchi S, Kitazawa S. Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy. Int. J. Gynecol. Obstet. 1994; 46; 321-324.
11. Kagami S, Kashimura M, Toki N, Katuhata Y. Myxoid leiomyosarcoma of the uterus with subsequent pregnancy and delivery. Gynecol. Oncol. 2002; 85; 538-542.
12. Kasahara K, Nishida M, Iijima S, Kaneko M. Uterine myxoid leiomyosarcoma. Obstet. Gynecol. 2000; 95; 1004-1006.
13. Kunzel KE, Mills NZ, Muderspach LI, D'Ablaing G. Myxoid leiomyosarcoma of the uterus. Gynecol. Oncol. 1993; 48; 277-280.
14. Mittal K, Popiolek D, Demopoulos RI. Uterine myxoid leiomyosarcoma within a leiomyoma. Hum. Pathol. 2000; 46; 41-47.
15. Nagata J, Nishi H, Nakamura A, Fukimo S, Kosaka J. A case of uterine myxoid leiomyosarcoma with positive cytology in pleural effusion. Acta Obstet. Gynecol. Jpn 1996; 48; 293-295.
16. Oruc S, Koyuncu F, Gürbüz N. Myxoid leiomyosarcoma of the uterus: a case report. Eur. J. Oncol. 1999; 20; 423-427.
17. Peacock G, Archer S. Myxoid leiomyosarcoma of the uterus: case report and review of the literature. Am. J. Obstet. Gynecol. 1989; 160; 1515-1518.
18. Pounder DJ, Iyer PV. Uterine leiomyosarcoma with myxoid stroma. Arch. Pathol. Lab. Med. 1985; 109; 762-764.
19. Salm R, Evans DJ. Myxoid leiomyosarcoma. Histopathology 1985; 9; 159-169.
20. Schneider D, Halperin R, Segal M, Maymon R, Bukovosky I. Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern - a case report. Gynecol. Oncol. 1995; 59; 156-158.
21. Shroff CP, Deodhar KP, Bhagwat AG. Myxoid leiomyosarcoma of the uterus - a case report with light microscopic and ultrastructural appraisal. Tumori 1984; 70; 561-566.
22. Vigone A, Giana M, Surico D, Leutner M, Surico N. Massive myxoid leiomyosarcoma of the uterus. Int. J. Gynecol. Cancer 2005; 15; 564-567.
23. Abeler V, Royne O, Thoresen S et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1990 to 2000 including 419 patients. Histopathology 2009; 54; 355-364.
24. Hsu S-M, Raine L. Versatility of biotin-labeled lectins and avidin-biotin-peroxidase complex for localization of carbohydrate in tissue sections. J. Histochem. Cytochem. 1982; 30; 157-161.
25. Hendrickson MR, Kempson RL. A diagnostic approach to smooth muscle tumours of the uterus. Curr. Diagn. Pathol. 2000; 6; 21-30.
26. Hendrickson MR, Tavassoli FA, Kempson RL, McCluggage WG, Haller U, Kubik-Huch RA. Mesenchymal tumors and related lesions of the uterine corpus. In Tavassoli FA, Devilee P eds. World Health Organization classification of tumours: tumours of the breast and female genital organ. Lyon: IARC Press, 2003; 233-244.
27. Moinfar F, Azodi M, Tavassoli FA. Uterine sarcomas. Pathology 2007; 39; 55-71.
28. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum. Pathol. 1993; 24; 1073-1077.
29. Feltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int. J. Gynecol. Pathol. 1995; 4; 89-96.
30. Ip PP, Lan KW, Cheung CL et al. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am. J. Surg. Pathol. 2007; 31; 1215-1224.
31. Sreenan JJ, Prayson RA, Biscotti CV et al. Histopathologic findings in 107 uterine leiomyomas treated with Leuprolide acetate compared with 126 controls. Am. J. Surg. Pathol. 1996; 20; 427-432.
32. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki67 expression in uterine smooth muscle tumors. Int. J. Gynecol. Pathol. 2008; 27; 326-332.
33. Mayerhofer K, Lozanov P, Bodner K et al. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcoma (LMS). Acta Obstet. Gynecol. Scand. 2004; 83; 1085-1088.
34. Sprogoe-Jakobsen S, Holund B. Immunohistochemstry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 1996; 104; 705-708.
35. Rabban JT, Zaloudek CJ, Skekitka KM, Tavassoli FA. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am. J. Surg. Pathol. 2005; 29; 1348-1355.
36. Shintaku M, Fukushima A. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Pathol. Int. 2006; 56; 625-628.
37. Clement PB, Young RH, Scully RE. Diffuse perinodular, and other patterns of hydropic degeneration within and adjacent to uterine leiomyomas: problems in differential diagnosis. Am. J. Surg. Pathol. 1992; 16; 26-32.
38. Oliva E, Young RH, Clement PB, Scully RE. Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int. J. Gynecol. Pathol. 1999; 18; 310-319.